Exclusive Ancillary Event: Advancing Research, Clinical Trial and RWE Applications in Ophthalmology

Sunday, 3 May 2026 | 5:15 PM – 9:00 PM I Hyatt Centric Downtown Denver

Join global experts to see how validated structural biomarkers and automated AI workflows are supporting research, clinical studies and real-world analysis with faster and deeper insights into retinal diseases, including GA, iAMD and nAMD. Get more information and sign up HERE. 

Reserve Your Spot - Limited Capacity

‍

Product Innovations: Experience the latest of RetinAI Discovery^®

Introducing RetinAI OCT Atlas^®
Get to know our latest CE-marked processor that merges RetinAI Layer Segmentation & Fluid Segmentation processors into a single, comprehensive powerhouse. By expanding the biomarker portfolio and target disease coverage, the RetinAI OCT Atlas^® provides clinicians and researchers with unprecedented depth in retinal disease assessment.

See LuxIA^® in Action
Come by our stand and learn about our latest AI-powered screening in adult diabetics for more-than-mild diabetic retinopathy (mtmDR) from color fundus images.

We are unveiling a seamless integration for high resolution, advanced imaging workflows that will redefine clinical efficiency. Visit us for an exclusive first look.

Book a 1:1 Demo at ARVO

‍

Scientific Excellence

Together with other Companies under the EssilorLuxottica medtech portfolio we are presenting 20+ scientific abstracts spanning Vision Care and Medical Technologies,including myopia management, vision science, advanced imaging, AI-driven retinal analytics, and light-based therapeutic technologies, highlighting our shared commitment to advancing clinical science.

‍

Research Publications Featuring RetinAI Discovery^®

The research publications featuring our technology presented at ARVO collectively signal a paradigm shift in retinal care: moving from manual, reactive observation to automated, predictive, and personalized medicine.

‍